12:28 PM
 | 
Jan 18, 2019
 |  BC Week In Review  |  Company News  |  Deals

Novartis to scale up data science under AI deal with Oxford

Novartis AG (NYSE:NVS; SIX:NOVN) and the University of Oxford's Big Data Institute (BDI) will use artificial intelligence to analyze ultra large and multiple data sets from Novartis' drug development programs to identify early predictors of patient response to treatments.

Under the five-year deal, the partners will apply BDI's statistical machine learning technology and advanced analytics to anonymized data from Novartis' clinical trials as well as from about 5 million patients...

Read the full 333 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >